Analyst Price Target is $7.50
▲ +57.23% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for ViewRay in the last 3 months. The average price target is $7.50, with a high forecast of $9.00 and a low forecast of $7.00. The average price target represents a 57.23% upside from the last price of $4.77.
Current Consensus is
The current consensus among 5 investment analysts is to buy stock in ViewRay. This Buy consensus rating has held steady for over two years.
ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.